Dolby Laboratories (NYSE:DLB) CAO Sells $77,226.24 in Stock

Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer directly owned 34,453 shares in the company, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Ryan Nicholson also recently made the following trade(s):

• On Monday, August 10th, Ryan Nicholson sold 1,348 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.04, for a total value of $83,629.92.
• On Tuesday, August 4th, Ryan Nicholson sold 357 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.63, for a total value of $21,644.91.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded down $2.48 during trading on Thursday, reaching $62.47. The company had a trading volume of 1,641,422 shares, compared to its average volume of 929,635. The firm has a market capitalization of $5.85 billion, a PE ratio of 26.58 and a beta of 0.80. The firm’s 50-day simple moving average is $55.49 and its 200 day simple moving average is $58.50. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $73.78.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company’s revenue was down 3.3% compared to the same quarter last year. During the same period last year, the firm posted $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Analysts anticipate that Dolby Laboratories will post 3.23 EPS for the current year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th were issued a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 annualized dividend and a yield of 2.3%. Dolby Laboratories’s dividend payout ratio is 61.28%.

Dolby Laboratories announced that its board has initiated a share repurchase plan on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to buy up to 7% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Weiss Ratings downgraded Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $83.00.

Institutional Trading of Dolby Laboratories

A number of hedge funds have recently added to or reduced their stakes in the stock. Paragon Capital Management Inc. acquired a new stake in shares of Dolby Laboratories during the 1st quarter valued at approximately $1,306,000. Hsbc Holdings PLC grew its holdings in shares of Dolby Laboratories by 396.1% in the 1st quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after acquiring an additional 24,958 shares during the period. Norges Bank acquired a new stake in shares of Dolby Laboratories in the 4th quarter worth approximately $54,966,000. Entropy Technologies LP purchased a new position in Dolby Laboratories in the 1st quarter valued at approximately $1,674,000. Finally, Pacer Advisors Inc. increased its stake in Dolby Laboratories by 8.0% in the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock valued at $31,008,000 after purchasing an additional 38,389 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Key Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Dolby is expanding beyond its traditional audio and video licensing markets into in-car gaming and live sports streaming. These initiatives could create additional licensing opportunities and support longer-term growth. Dolby Laboratories Expands Into In-Car Gaming and Live Sports Streaming
• Neutral Sentiment: Dolby announced that longtime CEO Kevin Yeaman will retire after nearly two decades with the company. Marc Whitten, a former Microsoft and Amazon executive, will become president, CEO and a member of Dolby’s board following a long-term succession process. The orderly transition may limit disruption, while investors will look for evidence that the new CEO can accelerate growth. Dolby Laboratories Announces Leadership Transition
• Neutral Sentiment: Zacks Research made several modest forecast adjustments. Estimates increased for fiscal 2027 first- and second-quarter EPS and third-quarter 2028 EPS, but the firm maintained a current-year consensus estimate of $3.23 per share. The mixed revisions suggest limited near-term earnings momentum rather than a major change in the outlook.
• Negative Sentiment: Zacks lowered estimates for fiscal 2026 fourth-quarter EPS to $0.87 from $0.91, fiscal 2027 EPS to $3.19 from $3.22, fiscal 2027 fourth-quarter EPS to $0.82 from $0.87, and fiscal 2028 EPS to $3.38 from $3.40. These cuts could pressure the stock by reinforcing concerns about slower earnings growth.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.